Tianjin Medical University General Hospital

This early-stage study is testing the safety of a personalized immune cell therapy for people with multiple early-stage lung cancer tumors. Doctors will collect a patient's own tumor-fighting immune cells, grow them in a lab, and then inject them back into the patient. The main g…

This early-phase study is testing the safety of a two-part treatment for advanced lung cancer that has become resistant to standard targeted drugs. It combines a patient's own tumor-fighting immune cells (called TILs) with a newer generation of the targeted drug they were already…

This study is testing whether a medication called roxadustat, currently used to treat anemia in kidney patients, can also help prevent or reduce muscle loss in people on dialysis. Researchers will compare roxadustat against standard anemia treatment in 60 dialysis patients who al…

This study compares two pain medications (oliceridine and sufentanil) given through patient-controlled pumps after lung surgery. The main goal is to see if one drug is better at preventing short-term pain from turning into long-term chronic pain. Researchers will follow 320 patie…